HealthEquity (NASDAQ:HQY) Rating Increased to Strong-Buy at Raymond James

Raymond James upgraded shares of HealthEquity (NASDAQ:HQY) from an outperform rating to a strong-buy rating in a research report report published on Tuesday morning, Marketbeat Ratings reports. They currently have $115.00 price objective on the stock, down from their previous price objective of $120.00.

Several other research firms have also commented on HQY. KeyCorp reduced their price target on HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Monday. Wells Fargo & Company boosted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. Mizuho began coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. Royal Bank of Canada boosted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Finally, Barrington Research restated an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, March 14th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $113.31.

HealthEquity Trading Down 0.1 %

NASDAQ:HQY opened at $90.19 on Tuesday. The business’s 50-day moving average is $104.40 and its two-hundred day moving average is $95.94. The firm has a market capitalization of $7.80 billion, a PE ratio of 82.74, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HQY. Holocene Advisors LP acquired a new stake in shares of HealthEquity in the third quarter valued at approximately $1,246,000. HighTower Advisors LLC grew its holdings in HealthEquity by 4.8% in the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company’s stock worth $9,122,000 after buying an additional 4,370 shares in the last quarter. Geneva Capital Management LLC increased its position in HealthEquity by 24.6% in the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock valued at $100,642,000 after acquiring an additional 206,894 shares during the period. BNP Paribas Financial Markets raised its stake in HealthEquity by 165.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company’s stock valued at $1,673,000 after acquiring an additional 12,745 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in HealthEquity by 2.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company’s stock worth $104,280,000 after acquiring an additional 25,004 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.